Luminex New Sample-to-Answer System for Infectious Disease Testing
Luminex Corporation will unveil its new sample-to-answer system for infectious disease testing, ARIES™ at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). ARIES' scalable throughput, easy to use design, and networked data management software will deliver rapid results with a simple workflow.
The five assay launch menu targeted for the ARIES system will include: Flu A/B and RSV, HSV 1&2, Norovirus and Clostridium difficile. Future menu items will be announced at a later date.
"ARIES will revolutionize molecular diagnostic testing with a system that integrates seamlessly into the laboratory," said Russell W. Bradley, senior vice president, corporate development and global marketing. "Enabling laboratories to produce faster results, and better manage their QC and compliance requirements can increase service levels to hospitals and doctors for improved patient care."
The unveiling will take place at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) May 11, 2014 at 11am CEST, booth #23. Russell W. Bradley will introduce the innovative sample-to-answer system, ARIES, and give a short demonstration.
Tags: Clostridium difficile, Influenza, Respiratory Syncytial Virus, Norovirus, Herpes Simplex Virus
Date Published: May 5, 2014
Source article link: Luminex Corporation » company contact details
Are You Prepared for the Flu Season Ahead?
CE Marked GenomEra® Norovirus Test for Stool Specimens
Arup Offers Explify™ Respiratory a NGS Test for Respiratory Infections
New Primer Pairs for LDTs for P. jirovecii, Group C and G Strep
FDA Clearance for ARIES C. difficile Assay Detecting both Toxin A and B